Journal of Orthopaedic and Sports Physical Therapy Revenue and Competitors
Estimated Revenue & Valuation
- Journal of Orthopaedic and Sports Physical Therapy's estimated annual revenue is currently $39M per year.
- Journal of Orthopaedic and Sports Physical Therapy's estimated revenue per employee is $267,300
Employee Data
- Journal of Orthopaedic and Sports Physical Therapy has 146 Employees.
- Journal of Orthopaedic and Sports Physical Therapy grew their employee count by 30% last year.
Journal of Orthopaedic and Sports Physical Therapy's People
Name | Title | Email/Phone |
---|
Journal of Orthopaedic and Sports Physical Therapy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.3M | 25 | -7% | N/A | N/A |
#2 | $503.8M | 1481 | 14% | N/A | N/A |
#3 | $11.4M | 52 | 16% | N/A | N/A |
#4 | $8.9M | 46 | -2% | N/A | N/A |
#5 | $53.2M | 199 | 5% | N/A | N/A |
#6 | $6.6M | 34 | 0% | N/A | N/A |
#7 | $39.8M | 149 | 2% | N/A | N/A |
#8 | $2101.4M | 6177 | 7% | N/A | N/A |
#9 | $27.2M | 112 | -6% | N/A | N/A |
#10 | $6M | 31 | -11% | N/A | N/A |
What Is Journal of Orthopaedic and Sports Physical Therapy?
The Journal of Orthopaedic & Sports Physical Therapy® (JOSPT®) publishes scientifically rigorous, clinically relevant content for physical therapists and others in the health care community to advance musculoskeletal and sports-related practice globally. To this end, JOSPT features the latest evidence-based research and clinical cases in musculoskeletal health, injury, and rehabilitation, including physical therapy, orthopaedics, sports medicine, and biomechanics.
keywords:N/AN/A
Total Funding
146
Number of Employees
$39M
Revenue (est)
30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $53M | 146 | 1% | N/A |
#2 | $7.5M | 147 | 4% | N/A |
#3 | $39.2M | 149 | 3% | N/A |
#4 | $23.8M | 149 | 6% | N/A |
#5 | $35M | 150 | 1% | N/A |